These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9372091)

  • 1. Myelodysplastic syndrome.
    Forman SJ
    Curr Opin Hematol; 1996 Jul; 3(4):297-302. PubMed ID: 9372091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell transplantation and intensified cytotoxic treatment for myelodysplasia.
    Boogaerts MA
    Curr Opin Hematol; 1998 Nov; 5(6):465-71. PubMed ID: 9814657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic marrow transplantation for myelodysplastic syndrome complicating autologous bone marrow transplantation.
    Bashir S; Cook P; Katz M; Mittelman A; Ahmed T
    Cancer Invest; 1994; 12(5):484-7. PubMed ID: 7922704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
    Aul C; Giagounidis A; Germing U; Ganser A
    Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes.
    Löffler H; Schmitz N; Gassmann W
    Hematol Oncol Clin North Am; 1992 Jun; 6(3):619-31. PubMed ID: 1613010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic and autologous stem cell transplantation in myelodysplastic syndromes.
    De Witte T
    Pathol Biol (Paris); 1997 Oct; 45(8):643-9. PubMed ID: 9569930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous stem cell transplantation in myelodysplastic syndromes.
    de Witte T; Suciu S; Brand R; Muus P; Kröger N
    Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.
    Bertz H; Spyridonidis A; Ihorst G; Engelhardt M; Grüllich C; Wäsch R; Marks R; Finke J
    Biol Blood Marrow Transplant; 2012 Jun; 18(6):894-902. PubMed ID: 22108569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of aggressive treatment strategies for myelodysplastic syndromes].
    Aul C; Germing U; Minning H; Kobbe G; Gattermann N; Südhoff T; Meckenstock G; Söhngen D; Heyll A
    Praxis (Bern 1994); 1999 Mar; 88(10):431-8. PubMed ID: 10199215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of aplastic anemia and myelodysplastic syndrome.
    Paquette RL
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):153-61. PubMed ID: 12380966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    de Witte T; Hermans J; Vossen J; Bacigalupo A; Meloni G; Jacobsen N; Ruutu T; Ljungman P; Gratwohl A; Runde V; Niederwieser D; van Biezen A; Devergie A; Cornelissen J; Jouet JP; Arnold R; Apperley J
    Br J Haematol; 2000 Sep; 110(3):620-30. PubMed ID: 10997974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
    Kobos R; Steinherz PG; Kernan NA; Prockop SE; Scaradavou A; Small TN; Shukla N; Khalaf R; O'Reilly RJ; Boulad F
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemopoietic stem cell transplantation for myelodysplastic syndrome.
    Deeg HJ; Appelbaum FR
    Curr Opin Oncol; 2000 Mar; 12(2):116-20. PubMed ID: 10750721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
    Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
    J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in biology and treatment of myelodysplasia.
    Heyman MR
    Curr Opin Oncol; 1991 Feb; 3(1):44-53. PubMed ID: 1710505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
    Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Al-Ali HK; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser AA; Egeler M; Cahn JY; Arnold R; Biersack H; Niederwieser D; de Witte T
    Leukemia; 2007 Sep; 21(9):1945-51. PubMed ID: 17611571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.
    Appelbaum FR; Barrall J; Storb R; Fisher LD; Schoch G; Ramberg RE; Shulman H; Anasetti C; Bearman SI; Beatty P
    Ann Intern Med; 1990 Apr; 112(8):590-7. PubMed ID: 2183666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia.
    Witherspoon RP; Deeg HJ
    Haematologica; 1999 Dec; 84(12):1085-7. PubMed ID: 10586209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.